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Abstract: This study was done to determine the protective activity of the hydroalcholic extract of Urtica dioica 
leaves on Hyperglycemia and ~-cells in hyperglycemic rats. Thirty Wistar rats were allocated in groups of 
normal, Diabetic and treatment. Hyperglycemia in Rats induced by 80 mg kg-1 streptozotocin. In treatment 
group, animals received hydroalcholic extract of Urtica dioica 100 mg kg-1 day-1 for five days, intraperitoneally 
and then hyperglycemia induced by streptozotocin. The blood glucose concentration was measured by using 
a Glucometer in 1st, 3rd and 5th weeks. In the end of 5th weeks the animals in each group were sacrificed by 
anesthesia and whole pancreas in three groups extracted and fixed in bouin's fluid and stained by chromealurn 
hematoxiline-phloxine and beta cells were collllted in three groups by Olympus microscope. Mean±SE of 
blood glucose concentrations in the end of fifth weeks were 99.4±5.0, 454.7±34.5 and 303.6±100.6 in control, 
diabetic and treatment groups, respectively (p<0.05). The percentages of ~-cells in control, diabetic and 
treatment groups were 73.6, 1.9 and 22.9%, respectively. The percentage of ~-cells in treatment group comparing 
with diabetic group was significant (p<0.05). This study showed that the protective administration of 
hydroalcholic extract of Urtica dioica has hypoglycemic effect and protective activity of ~-cells of langerhans 
in hyperglycemic rats. 
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INTRODUCTION 
Diabetes is a complex and multifarious group of 
disorders characterized by hyperglycemia reached 
epidemic proportions m the present century 
(Chen et al., 2005). 
More than 1 % of the entire world populations are 

victims of diabetes and their numbers are gradually 
increasing (Kar et al., 2003). 
In Iran high occurrence of the disease is noted, 
especially in urban populations and is therefore a major 
health problem. Plants used in folk medicine to treat 
diabetes mellitus represent a viable alternative for the 
control of this disease (Maroo et al., 2002). 
Urtica dioica (U. dioica), an annual and perennial 
herb of family Urticacea is commonly known as medical 
herb for a long time in the world. 
This herb is known for its anti-inflammatory activity 
(Obertreis et al., 1996; Riehemann et al., 1999). 
Furthermore, there have been also other reports indicating 
the benefits of using the extract of the leaves or other 
parts of the plant for the use in different conditions, i.e., 
diabetes (Kavalali et al., 2003; Roman Ramos et al., 1992; 

Petlevski et al., 2001; Farzami et al., 2003) as well as other 

disorders like prostatic hyperplasia (Hirono et al., 1994; 

Lichius and Muth, 1997; Kayser et al., 1995) rheumatoid 

arthritis, hypertension and allergic rhiintis (Millman, 1990) 

and stimulation of proliferation of human lymphocytes 

(Wagner et al., 1989) and decreasing the lipid peroxidation 
and liver enzymes (Kanter et al., 2003).

Althought, there are some reports about the
hypoglycemic activity 	 of U. dioica in folk medicine
(Petlevski et al., 2001; Farzami et al., 2003) but, in 
other hand, several investigations have detected
hyperglycemic activity 	of this herb (Neef et al., 1995;
Swanston-Flatt et al., 	 1989). Besides in our previous
study (Golalipour et al., 2006) clnonic administration of 
the extract of U. dioica leaves showed no hypoglycemic
effect of it in STZ diabetic rats. With regarding the lack of 
report about the protective effect of administration of this 
herb (before making diabetes) this research carried out to 
evaluate protective effect of the hydroalcholoic extract of 
U. dioica leaves on blood glucose concentration and 
potential protective roles in ~-cells of pancreas in 
diabetic rats. 
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MATERIALS AND METHODS 
Plant material: U. dioica leaves were collected from 
cultivated plant, from suburb of Gorgan, northern Iran 
(Golestan, Iran) in oct 2004 and taxonomically identified 
by Department of Pharrnacognosy, Mazandaran 
University of Medical Sciences. A voucher specimen 
(5-77-1) was deposited in the herbariurn of Mazandaran 
University. 
Preparation of plant extract: Powder of U. dioica leaves 
was perculated by hydroalcoholic ( 60°) solvent for 48 h. 
The extract was filtered and concentrated under vacuum 
at 40°C to made a jellies material. In addition to thin layer 
chromatography and purity tests (foreign matter, total 
ash, acid insoluble ash and water insoluble ash) for 
qualification analysis, monosaccharide-linked another 
reagent assay (spectrophotometry) have been carried out 
to determine the concentration of polysaccharides in 
U. dioica leaves for standardization of the extract. 
The results of phytochemical analysis showed the 
existence of high percentage of Tannins, Steroids and low 
levels of flavonids, carotenoids and saponins in leaves of 
U. dioica. 
Animals: Male adult albino rats (Wistar strain) of 
125-175 g were fed on pellet diet and tap water for full 
acclimatization. The animals were kept in air-conditional 
animal room (22±2°C) under a 12 h light/dark cycle. 
The rats were divided into three groups (each including 
10 rats). 
Experimental design: Hyperglycemia was induced with a 
single intrperiteonally (IP) injection of Streptozotocin 
(STZ) (80 mg kg-') to overnight fast rats. Streptozotocin 
(STZ) purchased from Sigma was dissolved in 
saline immediately use and intrperiteonally injected 
(80 mg kg-1 ). Blood samples for glucose measurements 
were taken from the tail vein. Diabetes was confirmed 
by measuring the glucose concentration by using 
Glucometer method. 
In the experiments, ten rats were used in each group. 
Group I: Normal control group. Saline daily for 5 days. 
Group II: Diabetic group. Saline daily for 5 days before 
STZ injection. 
Group III: Treatment Group: animals received 100 mg kg-1 
daily hydroalcholic extract of U. dioica, for 
5 days, intraperitoneally and then, 
hyperglycemia induced by intrperiteonally 
injection of 80 mg STZ. 
Glucose tolerance test: Intraperitoneal Glucose Tolerance 
Test (GIT) was performed on 16 h fasted rats using 
2 g glucose/kg body weight In all groups, blood was 
collected from the animals by tail sinpping at 0, 30, 90 and 
120 min after glucose load. Also glucose test were 
performed after IP injection STZ in 1, 3 and 5 weeks. 
Histopathologic examinations: The animals of three 
groups are sacrificed by ether anesthesia. Whole 
pancreas was dissected. The tissue samples were fixed in 
bouin's fluid and paraffin embedded for microscopic 
examination in accordance with routine laboratory 
procedures. Histopathologic examination and grading 
were carried out on Chromealum hematoxiline-phloxine 
(Gomori, 1941) stained. The number of islets and the 
number of ~-cells of each islet were counted by 
OLYJ\.1PUS microscope and we used OL YSIA software. 
The islet diameters were measured using calibrated 
micrometer by taking of fixed number of islet from the two 
experimental groups and one normal group. 
Statistical analysis: All the grouped data were 
statistically evaluated using Student's t-test, expressed as 
the Mean±SE from ten rats in each groups and A2 test. 
RESULTS 
The mean±SE of blood glucose concentrations before 
of STZ injection and before administration of U. dioica 
(in treatment group) were 85.5±1.7, 102.9±3.7 and 
95.6±3.7 mg dL-l in control, diabetic and treatment 
groups, respectively. One week after injection of STZ, the 
mean±SE of blood glucose concentration were 214.1±23.8 
and 277±45.7 mg dL -l in diabetic and treatment groups, 
respectively (Table 1 ). 
The effect of STZ in diabetic group showed a 
gradually increasing of blood glucose level which it 
was (214.1±23.8) m 1 week and it reached to 
( 454.7±34.5) mg dL _, in fifth week after injection of STZ. 
The mean±SE of Blood Glucose concentration level 
in treatment group decreased from 309.1±37.4 to 
303±100 mg dL_, in the fifth week 
In control group the mean±SE of Blood Glucose 
concentration had not any changes. Statistically analysis 
showed that there was a significant difference between 
treatment and control groups (p<0.05). Also this 
difference between diabetic and treatment group was 
significant (p<0.05). 
Table 1: Blood glucose concentration in control, diabetic and treatment 
rou s 
Blood glucose (mg dL 1) 
2 Initial 1 week 3week 5 week 
Control 85.5±1.7 87.5±1.9 90.2±2.7 99.4±5.0 
II Diabetic 102.9±3.7 214.1±23.8 243.3±34.8 454.7±34.5* 
Ill Urtica-Diabetic 95.6±3.7 277.1±45.7 309.1±37.4 303.6±100.6* 
*The significant difference between group II and group III relative to control 
in regard to glucose concentration, 1 =Groups, 2 =Treatments 
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Fig. 1: The result of Glucose Tolerance Test (GTf) that 
the Urtica dioica can cause shift down of GTT 
carve related to STZ group.[Control: Group (I), 
STZ: Group (II) and Urtica-STZ: Group (III)) 
Table 2: 	 The number of islets, total cells, the number and percents of P 
cells and islets area(µ) in pancreatic tissues in control, diabetic 
and treatment groups 
Islets Total cells P-cells P-cells Islets area 
(n) (n) (n) % (µ) 
I Control 14.7±2.2 277.3±17.7 204±15 73.6 588.8±28.7 
II Diabetic 5.8±1.1 *• 140.9±18.6*• 2.7±0.7*• 1.9 352.7±36*• 
III Urtica­ 13.0±2.6*• 128.3±18.6*• 29.4±11*• 22.9 399.7±37.4*• 
Diabetic 
*in regard to P-cells, differences were shown between group II and llL 
•(Mean±SE, p<0.001), 1 =Groups, 2 =Treatments 
Fig. 2: Pancreatic section from normal rat (group I). The 
beta cells are shown blue and alpha cells are red 
Staining Gomori's method, original magnification 
X400 [beta cells(+ ) alpha cells(+)] 
The same finding was appeared glucose tolerance 
test such as; we had shift-down (recovery) of GTT cmve 
after 4 weeks injection ofSTZ (Fig. 1 ). 
The histopathologic results depicted in Table 2 
andFig. 2-4. 
In this study the number of islets attd number of 
P-cells in pancreas tissue were 14.7±2.2 attd 204±15 in 
control group, respectively. These were 5.8±1.1 and 
2.7±0.7 in diabetic groups and 13±2.6 and 29.4±11 in 
treatment group, respectively. 
Fig. 3: Rat pancreatic tissue prepared from the Diabetic 
group (group II). The islet is atrophied and beta 
cells are decreased. Staining Gomoti's method, 
Original magnification X400 [(+ )beta cell,(+) 
alpha cell] 
Fig. 4: Rat pattcreatic tissue prepared from the protective 
group (group 111).The beta cells are shown blue 
and alpha cells are red Staining Gomoti's method, 
original magnification X 400 [beta cells(+ ) alpha 
cells(+)] 
The percentage of P-cell in control, diabetic and 
treatment groups were 73.6, 1.9 and 22.9%, respectively. 
The percentage of P-cells in treatment group with 
comparing to diabetic group was significant (p<0.05) 
(Table2). 
DISCUSSION 
This study showed that the administration of 
U. dioica leaves before induction of hyperglycemia in rats 
can prevent of severe increasing blood glucose 
concentration and disruption of P-cells in comparing with 
no treatment hyperglycemic rats. 
The screenings of medical herbs in two studies have 
not shown the hypoglycemia activity of aqueous extract 
ofU. dioica (Neefet al., 1995; Romatt Ramos et al., 1992). 
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Also hypoglycemic activity of U. dioica in normal 
rats has been shoV\Tll by other researches (Bnouham et al., 
2003; Petleveski et al., 2001 ). Bnouham concluded 
that anti-hyperglycemic activity of this herb is due 
to the decrease of transport from small intestine 
(Bnouham et al., 2003). 
Acute and chronic hypoglycemic activity of Utrica 
was demonstrated by Farzami in Iran (Farzami et al., 2003) 
and Kavalali in Turkey (Kavalali et al., 2003). Farzami 
showed that a fraction from U. dioica was a potent 
stimulator of insulin release of ~-cells. Kavalali tested the 
effect of lectin fraction of extract of U. pilulifera seed for 
their hypoglycemic activity and folllld hypoglycemic 
activity and ~-cell regenerative potency with seed of 
this herb. 
In our previous study the leaves extract of U. dioica 
had no hypoglycemic activity and ability to regenerate 
pancreatic ~-cells after four weeks of treatment in 
streptozotosin- diabetic rats (Golalipour et al., 2006). 
In our previous study, the animals probably the ~ 
cells damage is so extensive that no increase in insulin 
secretion is possible. However, in the present study we 
show a partial amelioration of ~-cell in diabetic rats. If 
STZ-induced diabetes is reversible, then it could be 
suggested that the active content of the leaves extract 
might play a protective role in preventing free-radicals 
actions, that may destroy ~-cell, those would then cause 
more secreatory ability of ~-cells this, decrease plasma 
glucose concentration. 
U. dioica probably prevented the disruption of 
~-cells of islets in the pancreas. In recent study, our 
results indicated that decreased blood glucose 
concentration by U. dioica pretreatment might be due to 
protective roles or partial regeneration in the ~-cells. 
However, other extra pancreatic mechanisms such as 
enhanced glucose transport into the cells, inhibition of 
the endogenous glucose production can not role out by 
the results of present study. 
STZ produce hyperglycemia in a concentration 
dependent model by selective ~-cell cytotoxic effect 
(Saini et al., 1999). The mechanism of action of STZ on 
rodent ~-cell is related to uptake of STZ into ~-cells and 
DNA strand breaks which then causes a lethal depletion 
of NAD, in the ~-cells (Swanston-Flatt et al., 1989; 
Saini et al., 1996). 
It has been shoV\Tll that inhibition of free radical 
scavenger enzymes and enhancing production of the 
superoxide radical are the mechanism of STZ on 
pancreatic ~-cells (Swanston-Flatt et al., 1989). 
The role of free radicals in disruption of insulin action 
and impairing glucose tolerance test was shown by Ford 
(Ford et al., 1996). 
Our findings suggest that U. dioica may have 
antioxidant or free radical scavenger properties. Thus, 
U. dioica may have a role in preventing of diabetes or 
slowing the progress of diabetic disease. 
Antioxidant and free radical scavenging properties of 
U. dioica leaves has been established by several studies 
(Kanter et al., 2005; Cetinus et al., 2005; Mavi et al., 2004). 
Preliminary phytochemical of the ethanolic extract of 
U. dioica was achieved according to the Trease and 
Evans method (Trease and Evan, 1983). Previous studies 
showed that antihyperglacemic activity of the U. dioica 
related to active component of U. dioica leaves such as 
flavonid, peptids and coxmarins (Ellnain et al., 1986; 
Adamski and Biegonska 1984; Rossiikaya et al., 1985). It 
has been suggested that the active natural compollllds 
might act by antioxidant and free radical scavengenng 
effect to cause the hypoglycemic activity. 
CONCLUSIONS 
This study showed that the extracts of Urtica dioica 
leaves can prevent from severe increasing of blood 
glucose concentration and also it protect of~ cells, if it is 
used before induction of hyperglycemia. Therefore, the 
usage of this plant can prevent from severity of diabetes 
in people with backgrolllld of diabetes. 
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